Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Chembiochem ; 18(7): 647-653, 2017 04 04.
Article in English | MEDLINE | ID: mdl-28125767

ABSTRACT

The broadly neutralizing HIV-1 antibody b12 recognizes the CD4 binding site of the HIV-1 envelope glycoprotein gp120 and efficiently neutralizes HIV-1 infections in vitro and in vivo. Based on the 3D structure of a b12⋅gp120 complex, we have designed an assembled peptide (b12-M) that presents the parts of the three heavy-chain complementarity-determining regions (CDRs) of b12, which contain the contact sites of the antibody for gp120. This b12-mimetic peptide, as well as a truncated peptide presenting only two of the three heavy-chain CDRs of b12, were shown to recognize gp120 in a similar manner to b12, as well as to inhibit HIV-1 infection, demonstrating functional mimicry of b12 by the paratope mimetic peptides.


Subject(s)
Anti-HIV Agents/immunology , Antibodies, Monoclonal/immunology , Antibodies, Neutralizing/immunology , HIV Envelope Protein gp120/immunology , HIV-1/immunology , Peptides/immunology , Anti-HIV Agents/chemical synthesis , Binding Sites , Cell Line , Humans , Immunoglobulin Heavy Chains/immunology , Peptides/chemical synthesis , Protein Engineering
SELECTION OF CITATIONS
SEARCH DETAIL
...